Could a repurposed drug put the brakes on Parkinson's?
NCT ID NCT02655315
Summary
This study tested whether a drug called deferiprone could slow the progression of Parkinson's disease. The drug works by removing excess iron from the brain, which researchers believe may contribute to the disease. The trial involved 372 adults with early-stage Parkinson's who were not yet on standard medications. Participants took either the drug or a placebo for nine months to see if it changed the course of their symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HP, Hôpital Pitié-Salpêtrière
Paris, France
-
Acadamic central center, Amsterdam
Amsterdam, Netherlands
-
CHU Pellegrin
Bordeaux, France
-
CHU de Strasbourg, Hôpital de Hautepierre
Strasbourg, France
-
CHU la TIMONE
Marseille, France
-
Cambridge University Hospital
Cambridge, United Kingdom
-
Centro Hospitalar Lisboa Norte
Lisbon, Portugal
-
Centro Hospitalar do Alto Ave
Guimarães, Portugal
-
Centro Hospitalar e universitario de Coimbra
Coimbra, Portugal
-
Charles University
Prague, Czechia
-
Christian-albrechts universität zu kiel
Kiel, Germany
-
Chu Purpan
Toulouse, France
-
Hospital Clinic Universitari de Barcelona
Barcelona, Spain
-
Hospital de Bellvitge
Barcelona, Spain
-
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
-
Hôpital Montpied
Clermont-Ferrand, France
-
Hôpital Salengro, CHRU
Lille, France
-
Hôpital Wertheimer
Bron, France
-
Klinik und Poliklinik für Neurologie der Universitätsmedizin Rostock
Rostock, Germany
-
Medizinische Universitat Innsbruck
Innsbruck, Austria
-
Newcastle University
Newcastle, United Kingdom
-
Radboud university medical center
Nijmegen, Netherlands
-
University Hospital, Saarland University
Homburg, Germany
-
University of Glasgow
Glasgow, United Kingdom
-
Univerzita Karlova V Praze
Prague, Czechia
Conditions
Explore the condition pages connected to this study.